Home > Financial Ratios > DR LAL PATHLABS
COMMUNITY POLL
for DR LAL PATHLABS
Please provide your vote to see the results

DR LAL PATHLABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 25.1926.7427.8634.9944.38

What is the latest EV/Core EBITDA ratio of DR LAL PATHLABS ?

The latest EV/Core EBITDA ratio of DR LAL PATHLABS is 25.19 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202525.19
Mar202426.74
Mar202327.86
Mar202234.99
Mar202144.38

How is EV/Core EBITDA of DR LAL PATHLABS Trending?

Years EV/Core EBITDA % Change
Mar2025 25.19
-5.80
Mar2024 26.74
-4.02
Mar2023 27.86
-20.38
Mar2022 34.99
-21.16
Mar2021 44.38 -

Other Financial Ratios of DR LAL PATHLABS


Compare EV/Core EBITDA ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹28,277.5 Cr -1.5% 11.9% 2.7% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹120,080.0 Cr 2% -1.6% 43.8% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹113,918.0 Cr 1.3% 7.4% 17.1% Stock Analytics
FORTIS HEALTHCARE ₹70,528.2 Cr -0.3% 13.3% 80.2% Stock Analytics
GLOBAL HEALTH ₹37,187.1 Cr 3% 5.4% 28.6% Stock Analytics
NARAYANA HRUDAYALAYA ₹37,059.8 Cr -1.1% -9% 47.2% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

-1.5%

11.9%

2.7%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses